115 related articles for article (PubMed ID: 8021913)
1. Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells.
John CS; Vilner BJ; Bowen WD
J Med Chem; 1994 Jun; 37(12):1737-9. PubMed ID: 8021913
[No Abstract] [Full Text] [Related]
2. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
6. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
8. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
[TBL] [Abstract][Full Text] [Related]
9. Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation.
Zamora PO; Moody TW; John CS
Life Sci; 1998; 63(18):1611-8. PubMed ID: 9806214
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Hou C; Tu Z; Mach R; Kung HF; Kung MP
Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
[TBL] [Abstract][Full Text] [Related]
11. N-(N-benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of sigma receptors.
Shiue CY; Shiue GG; Zhang SX; Wilder S; Greenberg JH; Benard F; Wortman JA; Alavi AA
Nucl Med Biol; 1997 Oct; 24(7):671-6. PubMed ID: 9352539
[TBL] [Abstract][Full Text] [Related]
12. A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.
John CS; Bowen WD; Saga T; Kinuya S; Vilner BJ; Baumgold J; Paik CH; Reba RC; Neumann RD; Varma VM
J Nucl Med; 1993 Dec; 34(12):2169-75. PubMed ID: 8254405
[TBL] [Abstract][Full Text] [Related]
13. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.
John CS; Lim BB; Geyer BC; Vilner BJ; Bowen WD
Bioconjug Chem; 1997; 8(3):304-9. PubMed ID: 9177835
[TBL] [Abstract][Full Text] [Related]
15. Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.
Caveliers V; Everaert H; John CS; Lahoutte T; Bossuyt A
J Nucl Med; 2002 Dec; 43(12):1647-9. PubMed ID: 12468514
[TBL] [Abstract][Full Text] [Related]
16. Influence of trishomocubanes on sigma receptor binding of N-(1-benzyl-piperidin-4-yl)-4-[123I]iodobenzamide in vivo in the rat brain.
Liu X; Mattner F; Katsifis A; Christie M; Kassiou M
Med Chem; 2005 Jan; 1(1):31-8. PubMed ID: 16789883
[TBL] [Abstract][Full Text] [Related]
17. N-(n-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of breast cancer.
Shiue C; Shiue GG; Benard F; Visonneau S; Santoli D; Alavi AA
Nucl Med Biol; 2000 Nov; 27(8):763-7. PubMed ID: 11150709
[TBL] [Abstract][Full Text] [Related]
18. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
[TBL] [Abstract][Full Text] [Related]
19. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
[TBL] [Abstract][Full Text] [Related]
20. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]